Analyst Research

Report Title Price
Provider : Stock Traders Daily
Provider : S&P Capital IQ – STARS Reports
Provider : Reuters Investment Profile
Provider : Pechala's Reports

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Sanofi SA's Genzyme to Build New Downstream Processing Facility for Fabrazyme

Tuesday, 15 Oct 2013 08:00am EDT 

Sanofi SA announced that its Genzyme is investing USD 80 million to build a new downstream processing facility for Fabrazyme (agalsidase beta). The new plant, which will be located adjacent to the new Fabrazyme cell culture manufacturing site in Framingham, Massachusetts, will expand purification capacity to support anticipated growth in global demand. 

Company Quote

31 Jul 2015